Clinical Trials Browser

Pharmaceutical Preparations × Thoracic × Clear all

NCT07443020 2026-04-07

RIOT 4B

Phase 1 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT04318938 2026-03-02

Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping

Phase 2 Active not recruiting

NSCLC

NCT07347977 2026-01-16

LidCRM

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT07192900 2026-01-15

(RIOT 4A)

Phase 1 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT03401385 2025-10-21

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

NCT03489616 2018-04-05

CRAGMOLC

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT01027676 2013-11-14

Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00285675 2006-05-31

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Phase 2 Unknown

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms